# Intraoperative Carbetocin to Decrease Blood Loss During Hysteroscopic Myomectomy

> **NCT04482959** · PHASE4 · COMPLETED · sponsor: **Mansoura University Hospital** · enrollment: 40 (actual)

## Conditions studied

- Myoma;Uterus

## Interventions

- **DRUG:** Carbetocin
- **DRUG:** Sodium chloride 0.9%

## Key facts

- **NCT ID:** NCT04482959
- **Lead sponsor:** Mansoura University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-15
- **Primary completion:** 2021-12-30
- **Final completion:** 2022-02-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04482959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04482959, "Intraoperative Carbetocin to Decrease Blood Loss During Hysteroscopic Myomectomy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04482959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*